Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ioline D Henter

Showing results (21-30 of 71) with videos related to

Pageof 8
Sort By:
Early Intervention in Psychiatry|August 4, 2009
Early intervention in bipolar disorder, part II: therapeuticsGiacomo Salvadore, Wayne C Drevets, Ioline D Henter, et al.
Progress in Neurobiology|August 17, 2021
A wake-up call: Sleep physiology and related translational discrepancies in studies of rapid-acting antidepressantsOkko Alitalo, Roosa Saarreharju, Ioline D Henter, et al.
Journal of Psychiatric Research|December 4, 2016
Case series: Antidepressant effects of low-affinity and low-trapping NMDA receptor antagonists did not predict response to ketamine in seven subjectsLauren Lepow, David A Luckenbaugh, Lawrence Park, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 20, 2023
Ketamine in neuropsychiatric disorders: an updateJenessa N Johnston, Bashkim Kadriu, Christoph Kraus, et al.
Early Intervention in Psychiatry|August 4, 2009
Early intervention in bipolar disorder, part I: clinical and imaging findingsGiacomo Salvadore, Wayne C Drevets, Ioline D Henter, et al.
The International Journal of Neuropsychopharmacology|November 17, 2018
Glutamatergic Neurotransmission: Pathway to Developing Novel Rapid-Acting Antidepressant TreatmentsBashkim Kadriu, Laura Musazzi, Ioline D Henter, et al.
Drug Discovery Today|August 6, 2019
The influence of ketamine on drug discovery in depressionChristoph Kraus, Daniel Wasserman, Ioline D Henter, et al.
Frontiers in Neuroscience|August 18, 2023
Non-canonical pathways in the pathophysiology and therapeutics of bipolar disorderRodrigo Machado-Vieira, Alan C Courtes, Carlos A Zarate, et al.
Annual Review of Pharmacology and Toxicology|January 8, 2014
Glutamate receptor antagonists as fast-acting therapeutic alternatives for the treatment of depression: ketamine and other compoundsMark J Niciu, Ioline D Henter, David A Luckenbaugh, et al.
Neuropharmacology|January 16, 2023
Ketamine and serotonergic psychedelics: An update on the mechanisms and biosignatures underlying rapid-acting antidepressant treatmentJenessa N Johnston, Bashkim Kadriu, Josh Allen, et al.
Pageof 8

Showing results (21-30 of 71) with videos related to

Sort By:
Pageof 8
Early Intervention in Psychiatry|August 4, 2009
Early intervention in bipolar disorder, part II: therapeuticsGiacomo Salvadore, Wayne C Drevets, Ioline D Henter, et al.
Progress in Neurobiology|August 17, 2021
A wake-up call: Sleep physiology and related translational discrepancies in studies of rapid-acting antidepressantsOkko Alitalo, Roosa Saarreharju, Ioline D Henter, et al.
Journal of Psychiatric Research|December 4, 2016
Case series: Antidepressant effects of low-affinity and low-trapping NMDA receptor antagonists did not predict response to ketamine in seven subjectsLauren Lepow, David A Luckenbaugh, Lawrence Park, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 20, 2023
Ketamine in neuropsychiatric disorders: an updateJenessa N Johnston, Bashkim Kadriu, Christoph Kraus, et al.
Early Intervention in Psychiatry|August 4, 2009
Early intervention in bipolar disorder, part I: clinical and imaging findingsGiacomo Salvadore, Wayne C Drevets, Ioline D Henter, et al.
The International Journal of Neuropsychopharmacology|November 17, 2018
Glutamatergic Neurotransmission: Pathway to Developing Novel Rapid-Acting Antidepressant TreatmentsBashkim Kadriu, Laura Musazzi, Ioline D Henter, et al.
Drug Discovery Today|August 6, 2019
The influence of ketamine on drug discovery in depressionChristoph Kraus, Daniel Wasserman, Ioline D Henter, et al.
Frontiers in Neuroscience|August 18, 2023
Non-canonical pathways in the pathophysiology and therapeutics of bipolar disorderRodrigo Machado-Vieira, Alan C Courtes, Carlos A Zarate, et al.
Annual Review of Pharmacology and Toxicology|January 8, 2014
Glutamate receptor antagonists as fast-acting therapeutic alternatives for the treatment of depression: ketamine and other compoundsMark J Niciu, Ioline D Henter, David A Luckenbaugh, et al.
Neuropharmacology|January 16, 2023
Ketamine and serotonergic psychedelics: An update on the mechanisms and biosignatures underlying rapid-acting antidepressant treatmentJenessa N Johnston, Bashkim Kadriu, Josh Allen, et al.
Pageof 8